Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. (2012)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S1470-2045(12)70377-7

PubMed Identifier: 22898679

Publication URI: http://europepmc.org/abstract/MED/22898679

Type: Journal Article/Review

Volume: 13

Parent Publication: The Lancet. Oncology

Issue: 9

ISSN: 1470-2045